BIIB

Biogen Idec Inc. News Headlines

$328.78
*  
1.20
0.37%
Get BIIB Alerts
*Delayed - data as of Sep. 18, 2014 13:36 ET  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Zacks Rank #1 Additions for Thursday - Tale of the Tape
9/18/2014 9:30:00 AM - Zacks.com

Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
9/18/2014 8:51:00 AM - Zacks.com

Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog
9/17/2014 7:15:00 PM - Zacks.com

Noteworthy ETF Inflows: VUG, BIIB, UPS, EBAY
9/17/2014 11:15:22 AM - BNK Invest

3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 10:52:17 AM - InvestorPlace Media

Alexion Names David Hallal COO - Quick Facts
9/17/2014 7:53:00 AM - RTT News

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
9/16/2014 9:30:00 AM - Zacks.com

Biogen/AbbVie Report Positive Data on MS Drug Zinbryta - Analyst Blog
9/15/2014 5:50:00 PM - Zacks.com

Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog
9/15/2014 4:45:00 PM - Zacks.com

Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog
9/12/2014 5:30:00 PM - Zacks.com

Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog
9/12/2014 4:30:00 PM - Zacks.com

4 Reasons Sangamo Biosciences Is Positioned For A Run-Up
9/12/2014 9:35:00 AM - Seeking Alpha

Why Biogen Idec Inc's Stock is Up 17% in 2014
9/12/2014 8:43:02 AM - Motley Fool

Novartis Presents Data on Multiple Sclerosis Drug Gilenya - Analyst Blog
9/11/2014 5:55:00 PM - Zacks.com

Biogen Idec's Phase 3 Study With Tecfidera Show Positive Data Over 5 Years
9/11/2014 7:59:00 AM - RTT News

Biogen Idec: PLEGRIDY Maintains Positive Treatment Effects In Phase 3 Trial
9/11/2014 7:46:00 AM - RTT News

Why Receptos Inc. Shares Rocketed Higher
9/10/2014 3:49:45 PM - Motley Fool

Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog
9/10/2014 11:17:00 AM - Zacks.com

Biogen Idec To Present At Morgan Stanley Conference; Webcast At 2:00 PM ET
9/8/2014 1:00:00 PM - RTT News

Biogen Idec To Present At Citi Biotech Conference; Webcast At 10:00 AM ET
9/4/2014 9:00:00 AM - RTT News

Determining Celgene's Fair Value
9/3/2014 11:24:00 AM - Seeking Alpha

5 Things Biogen Idec Inc's Management Wants You to Know
9/3/2014 9:17:02 AM - Motley Fool

IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 11:18:23 AM - BNK Invest

Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha

Biogen Idec: Health Canada Approves ELOCTATE - Quick Facts
8/26/2014 8:11:00 AM - RTT News